Medicare AdvantageCoverageMedium impact
MA05.071, Remote Electrical Neuromodulation for Migraines
Independence Blue Cross·Neurology, Pain Management·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
MA05.071 is a new medical policy effective January 1, 2026, establishing coverage criteria and billing guidelines for remote electrical neuromodulation (REN) devices used to treat migraines under Medicare Advantage plans. The billing team must implement this policy immediately to ensure proper claim submission and avoid denials for this newly covered service.
Action Required
By December 31, 2025: Billing team must obtain and review the complete MA05.071 policy text from the URL provided to identify specific CPT/HCPCS codes, prior authorization requirements, and documentation standards for remote electrical neuromodulation devices. Update billing system configuration, encounter forms, and provider education materials to reflect new coverage criteria before the January 1, 2026 effective date. Coordinate with neurology and pain management providers to ensure they understand documentation and authorization requirements. Failure to implement proper billing and authorization procedures will result in claim denials for migraine neuromodulation services.